News Detail
New Delhi, 22 Sept 2023: The Subject Expert Committee (SEC) on vaccines, which reviews proposals and advice the Drugs Controller General (India) (DCGI) in matters for biologicals and post approval change proposals, has recommended to grant permission to Gujarat-based Cadila Pharm......
View Details
Source : Pharmabiz
Subject Expert Committee
SEC
DCGI
biological
Cadila Pharmaceuticals
Varicella-Zoster Virus
VZV vaccine
New Drugs and Clinical Trials Rules
2019
WHO
Varicella
chickenpox
varicella-zoster virus
herpesvirus
Oka VZV
MMRV
ThRabis
Related News
- 1900 packings of fake Fair and Glow, Ponds Cream recovered (08-12-2023)
- India plans a digital Drug Regulatory System (08-12-2023)
- First Acute Kidney Injury Diagnostic Test Wins FDA Clearance (08-12-2023)
- Indian pharma companies recorded 9 percent 5-year CAGR (08-12-2023)
- Two crore alcoholic herbal syrup bottles sold across Saurashtra since 2023 (08-12-2023)
- Telangana DCA tightens noose against spurious drug manufacturers following seizure of spurious cancer drugs (08-12-2023)
- US FDA India & DIA India to host series of workshops on generic drug life-cycle management (08-12-2023)
- Gujarat: 8 arrested for manufacture, sale of beer in guise of Ayurvedic syrup (08-12-2023)
- WHO: More contaminated medicinal syrups found in new regions, including Southeast Asia (08-12-2023)
- IPC issues alert for painkiller mefenamic acid (08-12-2023)